    Vulnerable neural systems and the borderland of brain aging and neurodegeneration

    Neuron 77:219-234, 2013

    Jagust W

     http://www.ncbi.nlm.nih.gov/pubmed/23352159



    Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease

    Brain. 2013 Mar;136(Pt 3):844-58

    Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD

     http://www.ncbi.nlm.nih.gov/pubmed/23358601



    Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging

    Nature Neuroscience 16:357-364, 2013.

    Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP.

     http://www.ncbi.nlm.nih.gov/pubmed/23354332



    The aging brain and cognition: Contribution of vascular injury and Ab to mild cognitive dysfunction.

    JAMA Neurology Apri 1, 2013

    Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ

     http://www.ncbi.nlm.nih.gov/pubmed/23400560



    Association of gray matter atrophy with age, b-amyloid, and cognition in aging

    Cerebral Cortex Feb 6 2013

    Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ

     http://www.ncbi.nlm.nih.gov/pubmed/23389995





 

    Dopamine supports coupling of attention-related networks
  
    Journal of Neuroscience, 32(28):9582-9587. (2012)   

    Dang LC, O’Neil JP, Jagust WJ. 
  
     http://www.ncbi.nlm.nih.gov/pubmed/22787044   


  

    Striatal dopamine influences the default mode network to affect shifting between object features
   
    Journal of Cognitive Neuroscience, Sep;24(9):1960-70 2012  

    Dang LC, Donde A, Madison C, O’Neil JP, Jagust WJ.
   
     http://www.ncbi.nlm.nih.gov/pubmed/22640392


 

    Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks

    Neuroimage, Nov 8;66C:203-214

    Linh C Dang, James P O'Neil, and William J Jagust

     http://www.ncbi.nlm.nih.gov/pubmed/23142068

 

    Relative contributions of biomarkers in Alzheimer’s disease

    Annals of Epidemiology 22:868-875, 2012

    Haight TJ, Jagust WJ.

     http://www.ncbi.nlm.nih.gov/pubmed/23102709

 
    
    Apolipoprotein E, not fibrillar b-amyloid, reduces cerebral glucose metabolism in normal aging.

    Journal of Neuroscience, 32:18227-18233, 2012.

    Jagust WJ, Landau SM

     http://www.ncbi.nlm.nih.gov/pubmed/23238736




    Lifetime cognitive engagement is associated with low beta-amyloid deposition

    Archives of Neurology, epub Jan 23, 2012

    Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O’Neil JP. Wilson RS. Jagust WJ

     http://www.ncbi.nlm.nih.gov/pubmed/22271235


 

    Amyloid deposition, hypometabolism, and longitudinal cognitive decline 

    Annals of Neurology 72:578-586, 2012
   
    Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ.
     
     http://www.ncbi.nlm.nih.gov/pubmed/23109153



    Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods.

 
    Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA; for the Alzheimer’s Disease Neuroimaging Initiative.
     Journal of Nuclear Medicine Jan;54(1):70-7 2012

     http://www.ncbi.nlm.nih.gov/pubmed/23166389



    Predicting missing biomarker data in a longitudinal study of Alzheimer disease
   
    Neurology 78:1376-1382, 2012.

    Lo RY, Jagust WJ.
    
     http://www.ncbi.nlm.nih.gov/pubmed/22491869

 


    Vascular burden and Alzheimer pathological progression.

    Neurology, Sep 25;79(13):1349-55 2012

    Lo RY, Jagust WJ.

     http://www.ncbi.nlm.nih.gov/pubmed/22972646
   

  

    Alcohol consumption induces endogenous opiod release in the human orbitofrontal cortex and nucleus accumbens


    Mitchell JM, O’Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL

    Science Translational Medicine, 11:116ra6, 2012
     http://www.ncbi.nlm.nih.gov/pubmed/22238334



    Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant

    Neuroimage, 59:1152-1160, 2012

    Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks W, Baker SL, Jagust WJ

     http://www.ncbi.nlm.nih.gov/pubmed/21884802




    Effects of age and β-amyloid on cognitive changes in normal elderly people

    Neurobiology of Aging 2012

    Hwamee Oh, Cindee Madison, Thaddeus J. Haight, Candace Markley, William J. Jagust
   
http://www.sciencedirect.com/science/article/pii/S0197458012001534

 

    Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly

    Human Brain Mapping, epub  Sep 11, 2012
   
    Oh H, Habeck C, Madison C, Jagust W

http://onlinelibrary.wiley.com/doi/10.1002/hbm.22173/abstract




   Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals

   Arch Neurol. 2012 Feb;69(2):223-9.

   Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ.

    http://www.ncbi.nlm.nih.gov/pubmed/22332189


    The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Alzheimers Dement.  2011 May 7(3):270-9

    Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

     http://www.ncbi.nlm.nih.gov/pubmed/21514249




    Dopamine and frontostriatal networks in cognitive aging.

    Neurobiol Aging. 2011 Apr 19
   
    Klostermann EC, Braskie MN, Landau SM, O'Neil JP, Jagust WJ.

     http://www.ncbi.nlm.nih.gov/pubmed/21511369




   Lifespan brain activity, beta-amyloid, and Alzheimer’s diseaes.

   Jagust WJ and Mormino EC.

   Trends in Cognitive Sciences 15:520-526, 2011
    http://www.ncbi.nlm.nih.gov/pubmed/21983147




    Longitudinal Change of Biomarkers in Cognitive Decline.

    Arch Neurol. 2011 Jun 13.

    Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; for the Alzheimer's Disease Neuroimaging Initiative

     http://www.ncbi.nlm.nih.gov/pubmed/21670386



   Cerebrovascular disease, beta-amyloid and cognition in aging.

   Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust WJ

   Neurobiol Aging. 2011 Oct 31. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/22048124



   Ab deposition in aging is associated with increases in brain activation during successful memory encoding

   Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ

   Cerebral Cortex, epub Sept 23, 2011
    http://www.ncbi.nlm.nih.gov/pubmed/21945849



   Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging. <_static/pubs/Mormino_CerCor_2011_DMN.pdf

   Mormino EC, Smiljic A, Hayenga AO, H Onami S, Greicius MD, Rabinovici GD, Janabi M, Baker SL, V Yen I, Madison CM, Miller BL, Jagust WJ.

   Cereb Cortex. 2011 Mar 7
    http://www.ncbi.nlm.nih.gov/pubmed/21383234



   Amyloid versus FDG-PET in the differential diagnosis of AD and FTLD

   Rabinovici GD, Rosen HJ, Alkalay A, Kornak, J, Furst AJ, Agarwal N, Mormino EC, O’Neil JP, Janabi M, Karydas A, Growdon ME, Jang, JY, Huang EJ, DeArmond SJ, Trojanowski JQ, Grinberg LT, Gorno-Tempini ML, Seeley, WW, Miller BL, Jagust WJ.

   Neurology, 77: 2034-2042, 2011
    http://www.ncbi.nlm.nih.gov/pubmed/22131541



   Coronary risk correlates with cerebral amyloid deposition

   Reed BR, Marchant NL, Jagust WJ, DeCarli CS, Mack W, Chui HC

   Neurobiology of Aging epub Nov 9, 2011
    http://www.ncbi.nlm.nih.gov/pubmed/22078485



   Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

   Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

   Neurology. 2011 May 24;76(21):1789-96.
    http://www.ncbi.nlm.nih.gov/pubmed/21525424



   Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.

   Rostomian AH, Madison C, Rabinovici GD, Jagust WJ.

   J Nucl Med. 2011 Feb;52(2):173-9.
    http://www.ncbi.nlm.nih.gov/pubmed/21233181
   

   Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. 

   Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust WJ.

   Hum Brain Mapp. 2010 Jun 24.
    http://www.ncbi.nlm.nih.gov/pubmed/20578173



Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. 

   Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, Miller BL, Jagust WJ.

   Neurobiol Aging. 2010 Apr 22.
    http://www.ncbi.nlm.nih.gov/pubmed/20417582



   A BOLD move: clinical application of fMRI in aging. 

   Furst AJ, Mormino EC.

   Neurology. 2010 Jun 15;74(24):1969-76.
    http://www.ncbi.nlm.nih.gov/pubmed/20484684




   Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. 

   Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ.

   Lancet Neurol 9(1):119-28.
   
   http://www.ncbi.nlm.nih.gov/pubmed/20083042




   The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

   Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA; Alzheimer's Disease Neuroimaging Initiative.

   Alzheimers Dement. 2010 May;6(3):221-9.
    http://www.ncbi.nlm.nih.gov/pubmed/20451870



   Comparing predictors of conversion and decline in mild cognitive impairment. 

   Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

   Neurology. 2010 Jul 20;75(3):230-8.
    http://www.ncbi.nlm.nih.gov/pubmed/20592257




   β-Amyloid affects frontal and posterior brain networks in normal aging.
   
   Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ.

   Neuroimage. Feb 1 2011

   http://www.ncbi.nlm.nih.gov/pubmed/20965254


   Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

   Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR Jr, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW.

   Neurology 74(3):201-9.
   
http://www.ncbi.nlm.nih.gov/pubmed/20042704

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. 

   Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ.

Brain. 2010 Feb;133(Pt 2):512-28

   http://www.ncbi.nlm.nih.gov/pubmed/20080878





   Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration


   Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D’Esposito M.  

   Journal of Neuroscience 29:1538-1543

   http://www.ncbi.nlm.nih.gov/pubmed/19193900



   Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). 

   Haense C, Herholz K, Jagust WJ, Heiss WD.

   Dement Geriatr Cogn Disord. 28(3):259-66.

   http://www.ncbi.nlm.nih.gov/pubmed/19786778




   Relationships between biomarkers in aging and dementia.

   Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA; Alzheimer's Disease Neuroimaging Initiative.

   Neurology 73(15):1193-9.

http://www.ncbi.nlm.nih.gov/pubmed/19822868




   Mapping brain beta-amyloid.

   Jagust W.

   Curr Opin Neurol 22(4):356-61.

   http://www.ncbi.nlm.nih.gov/pubmed/19478666




   Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI 

   Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW,Jagust WJ, ADNI 

    Neurobiol Aging. 2011 Jul;32(7):1207-18

   http://www.ncbi.nlm.nih.gov/pubmed/19660834





   Striatal dopamine and working memory.   


   Landau SM, Lal R, O’Neil, JP, Baker S, Jagust WJ.  

   Cerebral Cortex, 19:445-454.
   
   http://www.ncbi.nlm.nih.gov/pubmed/18550595


 

   An inverse association of cardiovascular risk and frontal lobe glucose metabolism. 

   Kuczynski B, Jagust W, Chui HC, Reed, BR.   
   

   Neurology, 72:738-74.

   http://www.ncbi.nlm.nih.gov/pubmed/18550595

 
   Working memory capacity predicts dopamine synthesis capacity in the human striatum

   Cools R, Gibbs SE, Miyakawa A, Jagust W, D’Esposito M.  

   Journal of Neuroscience, 28:1208-1212

   http://www.ncbi.nlm.nih.gov/pubmed/18234898
   


   Relationship of striatal dopamine synthesis capacity to age and cognition. 

   Braskie MN, Wilcox CE, Landau SM, O'Neil JP, BakerSL, MadisonCM,Kluth JT, Jagust WJ 
 
   J Neurosci.  28(52):14320-8.

   http://www.ncbi.nlm.nih.gov/pubmed/19109513


   Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. 

   Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ
   
   Neurology. 2008 May 20;70(21):1980-3

   http://www.ncbi.nlm.nih.gov/pubmed/18401019

   

 
   Neuropathological basis of MR images in aging and dementia

   Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV,Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, SchuffN, DeCarli C, Chui HC. 
   
   Ann Neurol. 2008 Jan;63(1):72-80.

   http://www.ncbi.nlm.nih.gov/pubmed/18157909

   Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. 

   Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W
   
   Arch Neurol. 2008 May;65(5):650-5.

   http://www.ncbi.nlm.nih.gov/pubmed/18474742

 
   Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. 

   Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ.   
   
   Brain. 2009 May;132(Pt 5):1310-23

   http://www.ncbi.nlm.nih.gov/pubmed/19042931

 
   AB amyloid and glucose metabolism in three variants of primary progressive aphasia.

   Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O’Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML.
   
   Ann Neurol. 2008 October; 64(4): 388–401.

   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648510/


 
   11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

   Rabinovici GD, Furst AJ, O’Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ,  
   
   Neurology. 2007 Apr 10;68(15):1205-12.

   http://www.ncbi.nlm.nih.gov/pubmed/17420404

 

   Amyloid imaging in distinguishing atypical prion disease from Alzheimer’s disease. 
   
   Boxer AL, Rabinovici GD,Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O’Neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL,
   
   Neurology. 2007 Jul 17;69(3):283-90.

   http://www.ncbi.nlm.nih.gov/pubmed/17636066



   Automated template-based PET region of interest analyses in the aging brain.
   
   Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust WJ
   
   Neuroimage. 2007 Jan 15;34(2):608-17

   http://www.ncbi.nlm.nih.gov/pubmed/17112749

